Adrien Monard

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Newly Diagnosed

Ejection Fraction

Quality Improvement

Top Venues

Cancer chemotherapy and pharmacology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Emmanuelle Jacquet, Fiona Pham, Billy Taouk, Ghania Kerouani-Lafaye, Adrien Monard, Liora Brunel, Nicolas Albin
Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab. Cancer chemotherapy and pharmacology (2023)
Fiona Y-V Pham, Emmanuelle Jacquet, Amina Taleb, Adrien Monard, Ghania Kerouani-Lafaye, Florence Turcry, Liora Brunel, Françoise Grudé, Isabelle Yoldjian, Isabelle Sainte-Marie, Lotfi Boudali, Jean Yves Blay, Nicolas Albin
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019. International journal of cancer 151 (8) (2022)
Claire Christen, Laetitia Belgodère, Bernard Guillot, Céline Jumeau, Annie Lorence, Ghania Kerouani-Lafaye, Liora Brunel, Florence Turcry, Adrien Monard, Francoise Grudé, Gaëlle Guyader, Lotfi Boudali, Nicolas Albin
Access to innovation through the national early access program and clinical trials for patients with malignant melanoma. Cancer 127 (13) (2021)